$25/hr
·
Starting at
$25
Ongoing
The ACTION3 Phase 3 clinical trial conducted by Dimerix will study the effects of its lead drug, DMX-200, on patients with FSGS kidney disease.
Aussie clinical stage biotech Dimerix (ASX:DXB) has completed...
BiotechnologyClinical TrainingEpidemiologyHealingHealth Counseling